Records containing: Hepatic Encephalopathy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-09-22A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of MNK6105 (an Intravenous Formulation of L-Ornithine Phenylacetate) in Hospitalized Patients With Cirrhosis and Hyperammonemia Associated With an Episode of Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2021-09-16Multicenter, Randomized Phase 2B Study to Evaluate the Efficacy, Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in Hospitalized Patients With Cirrhosis and Associated Hyperammonemia With an Episode of Hepatic Encephalopathy (STOP-HE Study)
-
CLINICAL_TRIALS study record update · 2021-06-25Oculometric Testing for the Diagnosis of Covert Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2021-05-19Modulation of Gut-Brain Axis Using Fecal Transplant Capsules in Cirrhosis
-
CLINICAL_TRIALS study record update · 2021-05-10The Infusion of L-Ornithine L-aspart is as Effective as Nonabsorbable Disaccharides in the Management of Acute Hepatic Encephalopathy.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-03-16ClinicalTrials.gov study NCT04771104
-
CLINICAL_TRIALS study record update · 2021-03-08Probiotic E.Coli Nissle 1917 Comparing to Lactulose and Rifaximin in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2021-02-03Rifaximin and Its Microbial Resistance as a Secondary Prophylaxis of Hepatic Encephalopathy in Patients With HCV Related Cirrhosis
-
CLINICAL_TRIALS study record update · 2020-12-17Effect of Rifaximin on Driving Performance, Psychometric Test Performance and Quality of Life in Cirrhotic Patients With Minimal Hepatic Encephalopathy: Randomized, Double-blind, Placebo-controlled Trial.
-
CLINICAL_TRIALS study record update · 2020-11-03Evaluation of Minimal Hepatic Encephalopathy by a Neurophysiological Test in Patients With Hereditary Hemorrhagic Telangiectasia
-
CLINICAL_TRIALS study record update · 2020-09-04Efficacy of Combined Oral L-ornithine-L-aspartate and Oral Lactulose in Patients With Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2020-07-07Treatment of Hepatic Encephalopathy With Benzodiazepine Antagonist (Flumazenil) and Change in Cortical GABA Levels in Localized 1H-MR Spectroscopy
-
CLINICAL_TRIALS study record update · 2020-03-23Early Postoperative Continuous Renal Replacement Therapy After Liver Transplantation in Acute-on-chronic Liver Failure Patients With Overt Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2020-02-10A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study]
-
CLINICAL_TRIALS study record update · 2019-11-13Clinical Study Evaluating the Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-10-18Role of Magnetic Resonance Imaging in Detection of Minimal Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-09-17RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-09-09A Multicenter, Randomized, Open-Label, Active-Controlled, Trial to Evaluate the Safety and Efficacy of Rifaximin 550 mg With and Without Lactulose in Subjects With a History of Recurrent Overt Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-08-30Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial
-
CLINICAL_TRIALS study record update · 2019-08-14A Multi-Center, Open-Label Trial to Evaluate the Long-Term Safety and Tolerability of Rifaximin 550 mg BID in Subjects With a History of Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-08-14A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Tolerability of Rifaximin 550 mg BID For 6 Months In Preventing Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-08-09The Influence of Shunting Left/Right Portal Vein Branch on Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: a Multicenter Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2019-07-18Impact of Coenzyme Q10 and Meclofenoxate on Frequency and Severity of Hepatic Encephalopathy
-
CLINICAL_TRIALS study record update · 2019-06-17Therapeutic Efficacy of Oral PEG3350 Plus Lactulose Versus Lactulose Alone in Patients of Acute on Chronic Liver Failure With Overt Hepatic Encephalopathy: A Single Blind Prospective Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2019-04-09ClinicalTrials.gov study NCT02163837